Agenda
Click on the sessions for more information.
-
9:00 AM-11:00 AM EST In-Person Auditorium
9:00am - Pre-Conference: Growing the Workforce Seminar Introduction- Non-CME
Moderator:
Dr. Naomi Jay, RN NP PHD
Asst Prof of Medicine Department of Infectious Diseases (volunteer appointment)UCSF
-
11:30 AM-12:30 PM EST In-Person Foyer
11:30am - Lunch and Registration
-
Speakers:
- Dr Mayura Nathan, MBBS, FRCP (UK), Honorary Consultant Physician, Homerton Healthcare NHS Foundation Trust ; University College London.
- DR Belinda Nedjai, PhD, PGCAP, MSc., Associate Professor, Queen Mary University of London
-
1:10 PM-1:35 PM EST In-Person Auditorium
The Anal Microbiome and HPV: From Association to Clinical Application
Speakers:
Consultant in Infectious DiseasesHospital Universitario Ramón y Cajal
-
2:00 PM-2:40 PM EST In-Person Auditorium
Pathology and pathogenesis - Selected Oral Abstract Presentations - Non-CME
- Distinct Tumor Immune Microenvironment Profiles in Regressing versus Progressing Anal High-Grade Squamous Intraepithelial Lesions - Fernando Dias Gonçalves Lima
- Molecular Insights into the Natural History of Anal HSIL - Aude Jary
- Anal Swab-Specific Methylation Marker Discovery and Test Development for Objective Screening - Kirsten Rozemeijer
- Characterization of the Tumor Microenvironment of Premalignant and Malignant Anal Lesions - Cynthia Araradian
Speakers:
- Fernando Dias Goncalves Lima, MD, Research Physician, Amsterdam UMC
- Aude Jary, AP-HP, GHU Sorbonne Université, Pitié-Salpêtrière hospital
- Kirsten Rozemeijer, PhD, Epidemiologist, PostDoc, Department of Pathology, Amsterdam UMC
- Cynthia Araradian, General Surgery Resident, Oregon Health & Science University
-
Speakers:
Marta del Pino Saladrigues, MD; PhD
Dra.Hospital Clínic de Barcelona. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). Universitat de Barcelona
-
3:55 PM-4:15 PM EST In-Person
Anal Cancer in Women - Selected Oral Abstract Presentations - Non-CME
- Self-collected Anal HPV Testing in High-Risk Women without HIV: Performance and Acceptability - Keith Sigel
- Incidence Trends and Risk Factors for Anal Cancer in Women in a Large Integrated Health System - Navya Pothamsetty
Speakers:
- Dr. Keith Magnus Sigel, MD, PhD, MPH, Professor of Medicine, Icahn School of Medicine at Mount Sinai
- Navya Pothamsetty, MPH, Kaiser Permanente
- Self-collected Anal HPV Testing in High-Risk Women without HIV: Performance and Acceptability - Keith Sigel
-
Speakers:
- Dr Alison May Berner, BA (Hons), MBBS, MSc, PhD, MRCP (Medical Oncology)., Academic Clinical Lecturer in Medical Oncology, Queen Mary University of London
- Omar Harfouch, MD MPH, Assistant Professor of Medicine, University of Maryland, Baltimore
-
4:55 PM-5:50 PM EST In-Person Auditorium
Farrah Fawcett Foundation Keynote Address
Introduction by Dr. Lawrence Piro from the Farrah Fawcett Foundation
-
8:00 AM-9:00 AM EST In-Person Auditorium
Oral Abstracts - Research Forum 1 - Non-CME
- HSIL Risk After Negative Screening - Kirsten Rozemeijer
- Deep Learning and HPV Pleomorphic Multiorgans Induced Lesions: Automated Detection and Differentiation of Cervical and Anal Squamous Cancers Precursors - Miguel Mascarenhas
- Feminizing Gender-Affirming Hormone Therapy, HPV, and Precancerous Anal Lesions in High-Risk Populations: A Systematic Review - Manuel Valencia Echeverria
- Psychosocial Factors Associated with HPV Infection in Transgender Women in Argentina - Luciana La Rosa
- Risk Factors for Anal Human Papillomavirus (HPV) Infection and Anal HSIL Among Older Gay, Bisexual and Other Men Who Have Sex with Men (GBMSM) - Alexandra Hernandez
- Improving Screening Strategies for Detecting High-Grade Squamous Intraepithelial Lesions as a Predictor of Anal Cancer - Derek W. Ren
- The Addition of High-Risk HPV Testing as a Triage Tool in Anal Cancer Screening Optimizes the Referral Rate in a Canadian Cohort of Men Who Have Sex with Men Living with HIV - Troy Grennan
- Incidence of Anal High-Grade Squamous Intraepithelial Lesion (HSIL) Is High in Attendees of an Anal Cancer Screening Clinic in Vancouver, Canada: 2003-2021 - Troy Grennan
Speakers:
- Kirsten Rozemeijer, PhD, Epidemiologist, PostDoc, Department of Pathology, Amsterdam UMC
- Miguel Martins, MD, Gastroenterology Department, São João University Hospital
- Doctor Manuel Valencia Echeverria, General Surgery Resident, Surgery Resident, UNAM / ISSSTE
- Luciana La Rosa, MD, Staff, Centro Privado de Cirugía y Coloproctología / Fundación Huésped / CEMIC
- Dr. Alexandra Hernandez Lydia Hernandez, PhD, MPH, Professional Researcher/Associate Professor, University of California, San Francisco/Touro University California
- Derek W. Ren, B.S., UCLA College of Letters and Science, UCLA School of Nursing Research Affiliate, Staff Research Associate I, UCLA College of Letters and Science, Los Angeles, CA, USA
- Dr Troy Grennan, MD MSc FRCPC, Physician Lead, HIV/STI Program, BC Centre for Disease Control
-
Speakers:
- Dr. Sandy Hwang Fang, MD, Associate Professor of Surgery, Oregon Health and Science University
- Cynthia Araradian, General Surgery Resident, Oregon Health & Science University
-
Speakers:
Jenny Colleen McCloskey, MBBS,MPH, PhD
Head of Sexual Health ServicesRoyal Perth Hospital
-
Speakers:
Hamish Urquhart, FRACS MBBS (hons) BEng (biomech)(hons)
Colorectal SurgeonSt Vincent's Hospital, Sydney
-
10:10 AM-10:40 AM EST In-Person Auditorium
Treatment - Selected Oral Abstract Presentations - Non-CME
- Topical Tricholoracetic Acid VE Electrocautery for the Treatment of Anal Intraepithelial Neoplasia in Patients Living with HIV: A Multicentre Randomized Non-Inferiority Trial (TECAIN-STUDY) - David Chromy
- Radiofrequency Ablation - An Effective HSIL Treatment, Particularly Where HRA Capacity is Limited - Hamish Urquhart
- Long Term Outcome of Ablation for Male Anal HSIL: HSIL-Free Status is Key - Tamzin Cuming
Speakers:
- Hamish Urquhart, FRACS MBBS (hons) BEng (biomech)(hons), Colorectal Surgeon, St Vincent's Hospital, Sydney
- Ms Tamzin Cuming, MBBS MA(Cantab) FRCS (Gen Surg) FRCS (Eng) MEd, Consultant Colorectal Surgeon, Homerton University Hospital
- David Chromy, MD PhD, Medical University of Vienna
-
Speakers:
Mr David Finch, MBChB, BSc
PhD Clinical Research Fellow (Colorectal Surgery)University of Manchester
-
10:55 AM-11:15 AM EST In-Person Auditorium
Treatment Trials for Anal HSIL - Thoughts and Considerations...
Speakers:
Elizabeth Stier, MD
ProfessorBoston University Chobanian and Avedisian School of Medicine
-
Speakers:
Isabella Rosa-Cunha, Associate Professor of Medicine
Associate Professor of MedicineUniversity of Miami
-
Moderator:
- Dr. Lisa Flowers, MD, MPH, Professor, Emory University
- Iain Reeves, Consultant in HIV medicine, Homerton Healthcare NHS Trust
Panelist:
- Gary Bucher, M.D., Medical Director and Founder, Anal Dysplasia Clinic MidWest and Anal Dysplasia Consulting International
- Isobel Mary Poynten, Senior Research Fellow, University of NSW
- David Winterflood, CEO, Anal Cancer Foundation
- Prof Henry John de Vries, Dermatology, Amsterdam UMC & Public Health Service Amsterdam
- Dr Andrew Tin Yau Wong, MBBS, MPH, MSc, FRCP(London), FHKAM (Medicine), Hon Consultant, Infectious Disease Centre, Princess Margaret Hospital
- Luciana La Rosa, MD, Staff, Centro Privado de Cirugía y Coloproctología / Fundación Huésped / CEMIC
-
12:45 PM-1:15 PM EST In-Person Auditorium
Keynote Address: Anal Cancer - A suitable target for screening
-
1:15 PM-2:05 PM EST In-Person Foyer
Lunch
-
1:30 PM-2:00 PM EST In-Person Auditorium
Lunchtime - Oral Abstracts - Research Forum 2 - Non-CME
- SAVETHEBOTTOMS!!! Assessing the Gay Male Experience with Anal Cancer Screening in the United States - Elliot Arsoniadis
- High-Risk HPV Serotypes and the Extent of HSIL in the Anal Canal of People Living with HIV: A Case-Control Study - Agustin Castro Segovia
- HPV and Anal Cancer Awareness Among SMM with HIV: The Role of SMM-Affirming Clinics - Connor Volpi
- Psychometric Validation of the Adapted Champion Health Belief Model for Anal Cancer Screening Among People Living with HIV - John Fuller
Speakers:
- Dr Elliot George Arsoniadis, MD, PhD, Assistant Professor of Surgery, Department of Surgery, University of Minnesota
- Dr Agustin Castro Segovia, Coloproctology Fellow, Coloproctology Fellow, National Autonomus University of Mexico
- Connor Volpi, Johns Hopkins Bloomberg School of Public Health
- John Anthony Fuller, BS, PhD Student, Nell Hodgson Woodruff School of Nursing, Emory University
-
Speakers:
Andreia Albuquerque, MD PhD
Consultant Gastroenterologist and Associate ProfessorInstituto CUF Porto and Medical Science Department, Aveiro University
-
Speakers:
Dr Helle Kiellberg Larsen, PhD
ConsultantDepartment of Dermato-Venereology, Bispebjerg Hospital, Copenhagen, Denmark
-
3:05 PM-3:45 PM EST In-Person Auditorium
Screening high risk groups - Selected Oral Abstract Presentations - Non-CME
- The Pilot of Anal Screening Study (PASS): Anal Cancer Screening in People Living with HIV - Clare Dyer
- Swab-based Anal Cancer Screening in HIV-Positive Men: Projected Outcomes for Different Screening Algorithms - Kirsten Rozemeijer
- 2024 Anal Cancer Screening Guidelines: Analysis of Clinical Performance and HRA Utilization in a Large Cohort of Persons with HIV - Michael Gaisa
- Perianal Lesions in MSM Living with HIV is an Underappreciated Risk for Precancer and Cancer - Shima Rastegar
Speakers:
- Dr Clare Dyer, MPH, MIPH, PhD, Research Fellow, The Kirby Institute, UNSW Sydney
- Kirsten Rozemeijer, PhD, Epidemiologist, PostDoc, Department of Pathology, Amsterdam UMC
- Michael Gaisa, MD, Professor of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
- Shima Rastegar, M.D., Gynecologic Pathology Fellow, Icahn School of Medicine at Mount Sinai
-
3:45 PM-4:00 PM EST In-Person Foyer
Coffee/Tea Break
-
5:00 PM-5:30 PM EST In-Person Auditorium
Screening Diagnostics and AI - Selected Oral Abstract Presentations - Non-CME
- Anal Cytology for Anal Cancer Screening: Data from the ANCHOR Study - Julia Pugliese
- Proficiency and Certification Criteria for Clinicians Participating in the Anal Cancer HSIL Outcomes Research (ANCHOR) Trial - Naomi Jay
- Artificial Intelligence and Colposcopy: Automatic Identification of Vulvar Squamous Cell Carcinoma Precursors - Miguel Mascarenhas
Speakers:
- Julia Pugliese, MPH, ANCHOR Project Director, University of California, San Francisco
- Miguel Martins, MD, Gastroenterology Department, São João University Hospital
- Dr. Naomi Jay, RN NP PHD, Asst Prof of Medicine Department of Infectious Diseases (volunteer appointment), UCSF
-
9:00 AM-9:45 AM EST In-Person Auditorium
9am - Pre-Patient Panel: Blind spots, Opportunity, and Hope - Non-CME
Panelist:
- Dr. Amanda Ann Olson, PT, DPT, PRPC, Pelvic Health Physical Therapist, President of Intimate Rose, Intimate Rose
- Lauren Oliver, BSc (Hons), PGDip, MSc, FHEA, Lecturer in Therapeutic Radiography & Oncology, University of Liverpool
-
11:00 AM-11:30 AM EST In-Person Foyer
11am - Coffee/Tea Break
-
Speakers:
Audrey and Stanley Burton Professor of Clinical OncologyUniversity of Leeds
-
12:00 PM-12:40 PM EST In-Person Auditorium
12:00pm - Oncology - Selected Oral Abstract Presentations - Non-CME
- Sex-Disparities in Anal Cancer Staging: Is Vaginal Invasion as Clinically Relevant as Invasion into Other Organs? - Shefali Parikh
- Follow-Up After Anal Carcinoma (AC): Does HRA Decrease the Recurrence Rate? - Susanne Bock
- Challenges in Histological Diagnosis of Superficially Invasive Squamous Cell Carcinoma of the Anus (SISCCA) - Yuxin Liu
- Improving Follow-Up for People Treated with Anal Cancer - Andrew Yuk Tsun Wong
Speakers:
- Dr Shefali Pradeep Parikh, MBBS, FRCR, Clinical Oncology Registrar, University Hospitals Birmingham NHS Trust
- Susanne Bock, MD, FEBS (coloproctology), Colorectal Surgeon, HOCH Kantonsspital St. Gallen
- Yuxin Liu, MD, Professor of Pathology, Icahn School of Medicine at Mount Sinai
-
12:40 PM-1:40 PM EST In-Person Foyer
12:40pm - Lunch
-
2:05 PM-2:40 PM EST In-Person Auditorium
2:05pm - Closing Keynote: Moving the Needle Forward: Lessons from the ANCHOR Study
-
Speakers:
- Luis Barroso, MD, IANS President, International Anal Neoplasia Society
- Ms Tamzin Cuming, MBBS MA(Cantab) FRCS (Gen Surg) FRCS (Eng) MEd, Consultant Colorectal Surgeon, Homerton University Hospital
